Bachem Holding AG (BCHMY)
OTC
Closed
Aug 21, 2026
Day's Range
9.2552 wk Range
5.97Profile - BCHMY - Bachem Holding AG
Profile
Mic Code
PINX
Sector
Healthcare
Industry
Biotechnology
Employees
2.13K
Bachem Holding AG is a leading company in the pharmaceutical and biotechnology sectors, specializing in the development and manufacturing of peptides and oligonucleotides. Its primary function is to provide research-grade and custom synthesis products to the life sciences industry, playing a critical role in drug discovery and development. Renowned for its extensive expertise and innovation capabilities, Bachem serves a global customer base that includes pharmaceutical and biotech companies, research institutions, and academia. With a commitment to high-quality production standards and a focus on sustainable and efficient manufacturing processes, Bachem has significant market significance. It supports the advancement of new therapies, contributing to the evolution of healthcare solutions worldwide. Established in Switzerland, Bachem Holding AG continues to expand its influence through strategic investments in technology and infrastructure, reinforcing its position as a vital supplier in the life sciences industry.
Profile Details
Type
American Depositary Receipt
Ceo
Mr. Thomas Meier
Address
Hauptstrasse 144
City
Bubendorf
Zip
4416
Country
Switzerland
Phone
41 58 595 2021
Key Executives - BCHMY - Bachem Holding AG
Key executives
Cross Listings - BCHMY - Bachem Holding AG
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
